FDA approves ORBERA balloon for obesity treatment

ORBERA Intragastric Balloon, an Apollo Endosurgery device designed to treat obesity, has earned FDA approval.

Advertisement

The ORBERA is used to assist adult patients with a body mass index of 30 to 40 in weight loss and maintenance.

“While new to the United States, ORBERA is a weight loss device with more than 220,000 balloons distributed in over 80 countries and approximately 230 published papers documenting its clinical results,” said Todd Newton, CEO of Apollo Endosurgery.

More articles on gastroenterology:
Gastro Health acquires 3 private GI practices: 5 things to know
What do gastroenterologists do to relax?
5 GI physicians in the news – Aug. 7, 2015

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.